Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study - Top-Institutions - MDSpire

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

  • By

  • Huilin Lu

  • Tao Xu

  • Jing Li

  • Bufu Tang

  • Yulan Zeng

  • Xinghai Li

  • Jiangping Cun

  • Xiangwen Xia

  • Jihong Hu

  • Xuancheng Xie

  • Hongjie Fan

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Zhongda Hospital, Medical School, Southeast University
    Zhongda Hospital, Medical School, Southeast University

    Nanjing, Jiangsu

    Key Differentiators

    • Hepatology

  • #2

    China National Medical Products Administration
    China National Medical Products Administration

    Beijing, Beijing

    Key Differentiators

    • Regulatory Affairs

  • #3

    Sun Yat-Sen University First Affiliated Hospital
    Sun Yat-Sen University First Affiliated Hospital

    Guangzhou, Guangdong

    Key Differentiators

    • Hepatobiliary Surgery

  • #4

    Hunan Provincial People’s Hospital
    Hunan Provincial People’s Hospital

    Changsha, Hunan

    Key Differentiators

    • Hepatology

  • #5

    The First Affiliated Hospital of Jinan University
    The First Affiliated Hospital of Jinan University

    Jinan, Shandong

    Key Differentiators

    • Hepatology

Original Source(s)

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

  • by Huilin Lu, Tao Xu, Jing Li, Bufu Tang, Yulan Zeng, Xinghai Li, Jiangping Cun, Xiangwen Xia, Jihong Hu, Xuancheng Xie, Hongjie Fan

  • May 29, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series